
The arrival of zzso treatments The pathology of multiple sclerosis zzso took benefit from zzso of magnetic zzso and zzso studies, leading to the introduction of zzso agents and notably zzso beta zzso The therapeutic impact of such treatments in the zzso forms of the disease, and our improved knowledge on the natural history of the disease, raise the possibility of treating patients after the first zzso zzso This strategy may be more relevant in patients presenting poor zzso zzso zzso resonance imaging zzso data The clinical characteristics of the first episode do not help to predict the mean or long term zzso zzso resonance imaging has shown that the progression of the disease is partly zzso Other than data revealing zzso involvement and zzso zzso has also provided arguments suggesting early zzso zzso In a patient, the presence of high zzso load at onset on weighted zzso zzso of black holes and zzso enhancing zzso s on zzso zzso or the presence of new zzso on zzso conducted a few Months later are all zzso factors of clinical progression and suggest that treatment should be initiated zzso The interest of zzso beta Two clinical trials have shown that treatment with zzso treatment after a first zzso event significantly decreased the risk of a second episode in the short zzso The aim of such treatment would be to limit the irreversible zzso zzso notably in the form of zzso sections often associated with inflammatory zzso An early reduction in the inflammatory response could lead to a lesser number of zzso and, consequently, reduced clinical zzso 

